PACS Group, Inc.
NYSE:PACSFinancial - Conglomerates
+$0.41 today
- Market cap
- $7.35B
- Beta
- 0.00
- P/E (TTM)
- 23.0
- EPS (TTM)
- $1.55
Volume 0.78M
Average 0.84M
PACS Total Non-current Liabilities
All obligations due after more than one year.
PACS Group, Inc.NYSE: PACS
Total Non-current Liabilities · Q2 FY2026 · quarter ended Jun 2026
Total non-current liabilities broadly unchanged from a year ago
Total non-current liabilities stood at $3.49B at the end of Q2 FY2026, down 1.0% from a year earlier and down 1.7% from the prior quarter. Over 3 fiscal years it compounded at +23.9% a year.
Context
- Total non-current liabilities amounted to 61.6% of total assets at the end of Q2 FY2026, down 2.4 pp from a year earlier.
- Total non-current liabilities increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether total non-current liabilities keeps falling in the next quarterly balance sheet after a -1.0% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Non-current Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 3.63B USD
- Year-over-year change
- +2.3%
- 3-year CAGR
- +23.9%
| Period | Period end | Total Non-current Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 3.63B | +2.3% |
| FY2024 | 2024-12-31 | 3.55B | +20.1% |
| FY2023 | 2023-12-31 | 2.95B | +54.7% |
| FY2022 | 2022-12-31 | 1.91B | — |
Total Non-current Liabilities vs competitors
How PACS compares with its peers on the latest reported figures
- PACS's Jun 2026 total non-current liabilities of $3.49B is the 4th highest of the 11 companies compared; the peer median is $1.54B.
- Its year-over-year change of -1.0% is the 10th highest of 11, against a peer median of +8.4%.
- Total non-current liabilities amounts to 61.6% of total assets for PACS, versus a peer median of 42.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $44.53B | -0.7% | +3.4% | 73.6% | |
| Mar 2026 | $11.58B | -9.9% | -3.6% | 87.8% | |
| Sep 2026 | $5.45B | +1.3% | +7.4% | 92.0% | |
| Jun 2026 | $3.49B | -1.0% | +23.9% | 61.6% | |
| Jun 2026 | $3.12B | +10.3% | -2.4% | 41.9% | |
| Jun 2026 | $2.42B | +12.3% | +12.9% | 42.1% | |
| Sep 2026 | $653.05M | +182.0% | -0.3% | 31.6% | |
| Mar 2026 | $438.47M | +31.8% | +12.2% | 45.8% | |
| Jun 2026 | $429.6M | -0.2% | -3.5% | 19.7% | |
| Mar 2026 | $330.83M | +6.6% | +9.5% | 34.6% | |
| Mar 2026 | $92.61M | +112.3% | +7.6% | 16.9% | |
| Peer median (excluding PACS) | $1.54B | +8.4% | +5.4% | 42.0% | |
Competitors are the stored peer set for PACS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|
| Cash & Equivalents | 58.27M | 73.42M | 157.67M | 197.02M |
| Short-term Investments | 0 | 0 | 0 | 0 |
| Net Receivables | 420.12M | 600.07M | 716.52M | 702.09M |
| Inventory | 0 | 0 | 0 | 0 |
| Other Current Assets | 32.77M | 48.67M | 64.07M | 170.63M |
| Total Current Assets | 511.16M | 722.15M | 938.26M | 1.07B |
| Property, Plant & Equipment (Net) | 1.78B | 2.59B | 3.99B | 4.17B |
| Goodwill | 55.22M | 59.02M | 60.79M | 61.79M |
| Intangible Assets | 6.27M | 6.27M | 6.27M | 6.27M |
| Long-term Investments | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 113.63M | 139.96M | 252.49M | 276.96M |
| Total Non-current Assets | 1.95B | 2.79B | 4.3B | 4.51B |
| Total Assets | 2.46B | 3.51B | 5.24B | 5.58B |
| Account Payables | 110.58M | 140.95M | 175.06M | 192.23M |
| Short-term Debt | 61.36M | 16.82M | 156.85M | 4.46M |
| Tax Payables | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 0 | 0 | 145.8M | 181.13M |
| Total Current Liabilities | 483.86M | 456.93M | 978.43M | 1B |
| Long-term Debt | 438.34M | 715.71M | 250.98M | 344.8M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 166.26M | 276.38M | 362.03M | 345.5M |
| Total Non-current Liabilities | 1.91B | 2.95B | 3.55B | 3.63B |
| Total Liabilities | 2.39B | 3.41B | 4.53B | 4.63B |
| Common Stock | 129K | 129K | 155K | 157K |
| Retained Earnings | 63.52M | 96M | 118.04M | 309.58M |
| Accumulated OCI | 0 | 0 | 0 | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 |
| Minority Interest | 5.01M | 5.6M | 6.14M | 5.68M |
| Total Equity | 68.65M | 101.73M | 715.69M | 952.45M |
| Total Debt | 1.93B | 2.8B | 3.5B | 3.47B |
| Net Debt | 1.87B | 2.73B | 3.34B | 3.27B |
PACS Group, Inc.
NYSE:PACS
Intrinsic Alpha fair value
Locked
Current Price
$46.30
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.